Auryon
A powerful weapon against peripheral artery disease: The Auryon system relies on the most advanced atherectomy technology to clear all types of lesions, including in-stent restenosis (ISR). With a single device, you can treat above and below the knee through femoral, pedal, or radial access.
- purpose-built hydrophilic catheters designed to treat all levels of calcification
- targets infrainguinal lesions above and below the knee (even below the ankle)
- indicated for ISR and suitable to treat acute limb ischemia (ALI)
Precision
- optimized wavelength and pulse width to treat all lesions while helping to preserve vessel wall endothelium
- targeted biological reactions to address risk of perforations
- non-reactive to contrast media for simultaneous ablation and observation of fluoroscopy image
- built-in aspiration to minimize risk of embolization and dissection
Efficiency
- mobile device
- using 110 V outlet
- touch screen
- low acoustic noise emission
- potential to debulk in fewer passes
- easy installation and storage
Registry study 2024
“... the 355 nm laser system is safe and effective in a real-world setting for performing atherectomy in patients with infrainguinal PAD.”
Das et al. Catheter Cardiovasc Interv 2024. DOI: 10.1002/ccd.31023
Prospective multi-center study 2024
“... the Auryon laser is safe and relatively effective in treating BTK lesions with minimal complications.”
Shammas et al. Am J Cardiol 2024. DOI: 10.1016/j.amjcard.2024.03.008
Histologic study 2023
“Our pilot data suggests Auryon laser may be a promising therapy for calcified lesions.”
Rundback et al. Cardiovasc Revasc Med 2023. DOI: 10.1016/j.carrev.2023.06.027